KURA FY 2017 Earnings — Kura Oncology, Inc. Revenue & Financial Results | Market Cap Arena

KURAKura Oncology, Inc.

$774M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$30,000

Operating Income

-$36M

Net Income

-$35M

EPS (Diluted)

$-1.52

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$28M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$96M

Total Liabilities

$16M

Stockholders' Equity

$80M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$30,000	-$31,000	+3.2%
Operating Income	-$36M	-$28M	-27.2%
Net Income	-$35M	-$28M	-28.6%